Albany, NY -- (SBWIRE) -- 01/10/2018 -- Drug intermediates are the drugs used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry. Pharmaceutical companies use drugs intermediates for research and development purposes. Pharmaceutical intermediates, veterinary drug intermediates, and bulk drug intermediates are various types of drug intermediates. The global drug intermediate market is expected to grow at a high rate owing to rising research and development activity globally.
The market of drug intermediates is segmented on the basis of type of intermediate, end user, and by region. On the basis of type of intermediate, the market is segmented into two main types, API intermediate, and advanced intermediate. API or active pharmaceutical ingredient intermediates are the raw materials or raw drugs responsible for therapeutic action. They are the active ingredients which are later converted into various forms such as tablets, capsules, suspensions etc. API acts as a drug itself. Advanced intermediates are advanced forms of drug intermediates. Advanced intermediate drugs are used to perform drug interaction activity which formed in new chemical products. Capecitabine intermediates, imatinib intermediates, lenalidomide intermediates, pemetrexed intermediates, nilotinib intermediates, temozolamide intermediates, gemcitabine intermediates, afatinib intermediates, pazopanib intermediates, and ibrutinib intermediates are few examples of drug intermediates.
Request Brochure of The Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31493
On the basis of end user, the global drug intermediate market is segmented into pharmaceutical industry, biotechnology industry, and chemical industry. Drug intermediates are available in various forms such as moderate quality drug intermediates, high quality intermediates, and premium quality intermediates. The high and premium quality drug intermediates are used mainly for research purposes. There has been an ever increasing demand for drug intermediates in the global market due to the fast growing biotechnology and life sciences sectors, along with rising adoption and increasing application of drug intermediates in research fields. Pharmaceutical companies and biotechnology companies, along with research companies around the world have shown growing focus toward R&D in drug discovery and development, New methods and technologies in the equipment for synthesizing drug intermediate with manufacturers providing numerous customizations in the synthesized drugs, has widened the scope of applications and led to increasing demand for drug intermediate in the global market.
By geography, the market for drug intermediates is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific leads the drug intermediate market owing to rising pharmaceutical and life sciences industry in the region especially in emerging markets in countries such as India and China. Europe is the second leading market for drug intermediates due to development and expansion of more efficient and advanced technologies. The Asia Pacific drug intermediate market is also anticipated to expand at an increasing rate owing to increasing healthcare spending, adoption of western lifestyle, and growth in research and development. Asia Pacific is the fastest growing region for the drug intermediate market as several players have invested in the development and manufacturing of drug intermediates. These factors are expected to drive the market growth of drug intermediates during the forecast period.
Request Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=31493
Key players in the global antithrombotic/anticoagulant drugs market are Ami Lifesciences, Accrete Pharmaceuticals Pvt. Ltd, A. B. Enterprises, Ramdev Chemicals Pvt. Ltd., Clearsynth, Aarti Drugs Ltd., Synpure Labs, and Karvy Therapeutics Pvt. Ltd among others. The rising competition in the pharmaceutical and biotechnology industry for outsourcing of drug intermediates and manufacturing of drug intermediates is expected to boost the growth of the global drug intermediate market during the forecast period.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Report Details @ https://www.transparencymarketresearch.com/drug-intermediate-market.